Charles Lee Nuzum Sr., Director at Predictive Oncology Inc. (POAI), bought 200,000 shares at $0.31 ($62K) on 2022-05-20, disclosed to the SEC on 2022-05-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.